Garrood P, Eagle M, Jardine P E, Bushby K, Straub V
Institute of Human Genetics, International Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK.
Neuromuscul Disord. 2008 Jan;18(1):71-3. doi: 10.1016/j.nmd.2007.07.006. Epub 2007 Aug 23.
Myoglobinuria is a recognised complication of Duchenne muscular dystrophy (DMD), but has only once been reported in ambulant boys on corticosteroid therapy [Dubowitz V, Kinali M, Main M, Mercuri E, Muntoni F. Remission of clinical signs in early Duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy. Eur J Paediatr Neurol 2002;6(3):153-9.]. We present three prednisolone-treated boys with myoglobinuria and in two cases this was recurrent. All three showed improved motor performance in response to the introduction of corticosteroids. The greater activity of steroid-treated individuals may place their dystrophin-deficient muscles under greater mechanical stress, predisposing to further muscle fibre damage and consequent myoglobinuria. Families and physicians need to have an increased awareness of this possibility and of the appropriate management of myoglobinuria.
肌红蛋白尿是杜氏肌营养不良症(DMD)的一种公认并发症,但仅在接受皮质类固醇治疗的能行走男孩中报告过一次[杜博维茨V、基纳利M、梅因M、梅尔库里E、蒙托尼F。间歇性低剂量泼尼松龙治疗早期杜氏肌营养不良症临床症状的缓解。《欧洲儿科神经病学杂志》2002年;6(3):153 - 9。]。我们报告了三名接受泼尼松龙治疗出现肌红蛋白尿的男孩,其中两例为复发性。所有三例在开始使用皮质类固醇后运动表现均有改善。接受类固醇治疗的个体活动量增加,可能使其缺乏抗肌萎缩蛋白的肌肉承受更大的机械应力,易导致进一步的肌纤维损伤及随之而来的肌红蛋白尿。家庭和医生需要提高对这种可能性以及肌红蛋白尿适当管理的认识。